<DOC>
	<DOC>NCT00201903</DOC>
	<brief_summary>To explore the relationship between tissue factor levels, tumour progression, activation of blood coagulation and venous thromboembolism with malignant glioma</brief_summary>
	<brief_title>The Roles of Tissue Factor in Malignant Gliomas</brief_title>
	<detailed_description>To explore the relationship between tissue factor levels, tumour progression, activation of blood coagulation and venous thromboembolism with malignant glioma</detailed_description>
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<mesh_term>Thromboplastin</mesh_term>
	<criteria>participation in PRODIGE adult patients newly diagnosed, biopsyconfirmed grade III/IV malignant gliomas undergone craniotomy or stereotactic biopsy &gt; 2 days and &lt; 4 weeks before have known hereditary thrombophilia are receiving experimental antiangiogenic therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>venous thromboembolism</keyword>
	<keyword>brain tumours</keyword>
	<keyword>glioma</keyword>
	<keyword>tissue factor</keyword>
	<keyword>blood coagulation</keyword>
	<keyword>tumour progression</keyword>
	<keyword>low molecular weight heparin</keyword>
</DOC>